Market Cap (In USD)
290.19 Million
Revenue (In USD)
39.29 Million
Net Income (In USD)
-41.19 Million
Avg. Volume
334.14 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.4-33.135
- PE
- -
- EPS
- -
- Beta Value
- 1.109
- ISIN
- US1266381052
- CUSIP
- 126638105
- CIK
- 1235912
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Kevin Hykes
- Employee Count
- -
- Website
- https://www.cvrx.com
- Ipo Date
- 2021-06-30
- Details
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
More Stocks
-
SUPER
-
ZBRA
-
IPD
-
AMEZ
-
ECGIECGI Holdings, Inc.
ECGI
-
2528
-
8715
-
SATINDLTDSat Industries Limited
SATINDLTD